Literature DB >> 1848223

A dominant negative G alpha s mutant is rescued by secondary mutation of the alpha chain amino terminus.

S Osawa1, G L Johnson.   

Abstract

The Gs protein alpha subunit, alpha s, stimulates the activity of adenylyl cyclase. The sequence 223Asp-Val-Gly-Gly-Gln227 in the alpha s polypeptide is predicted to interact with the gamma-phosphate of GTP and mediate the conformational change involved in alpha s activation. Mutation of the alpha s polypeptide within this region at Gly225----Thr had two demonstrative phenotypic effects when expressed in COS-1 cells: the mutant alpha s chain was ineffective in activating adenylyl cyclase and inhibited in a concentration-dependent manner the beta-adrenergic receptor stimulation of cAMP synthesis. Thus, the Gly225----Thr mutation alters the ability of GTP to activate the alpha s chain and when overexpressed the mutant polypeptide exerts a dominant negative phenotype. Mutation at the amino terminus which creates a constitutively active alpha s rescued the inhibited state of the Gly225----Thr mutant when both mutations were encoded in the same polypeptide. This finding defines the amino terminus as a functional regulatory domain controlling the properties of the GTP/GDP binding site of G protein alpha subunit polypeptide chains.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848223

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Allosteric determinants in guanine nucleotide-binding proteins.

Authors:  Mark E Hatley; Steve W Lockless; Scott K Gibson; Alfred G Gilman; Rama Ranganathan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

2.  Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells.

Authors:  G Kalinec; A J Nazarali; S Hermouet; N Xu; J S Gutkind
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

3.  Myristoylation of the G alpha i2 polypeptide, a G protein alpha subunit, is required for its signaling and transformation functions.

Authors:  C Gallego; S K Gupta; S Winitz; B J Eisfelder; G L Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

4.  Dominant negative mutants of transducin-alpha that block activated receptor.

Authors:  Michael Natochin; Brandy Barren; Nikolai O Artemyev
Journal:  Biochemistry       Date:  2006-05-23       Impact factor: 3.162

5.  A Gsalpha mutant designed to inhibit receptor signaling through Gs.

Authors:  T Iiri; S M Bell; T J Baranski; T Fujita; H R Bourne
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

6.  Activating and inactivating mutations of the alpha subunit of Gi2 protein have opposite effects on proliferation of NIH 3T3 cells.

Authors:  S Hermouet; J J Merendino; J S Gutkind; A M Spiegel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

7.  Spatial and temporal expression of the Dictyostelium discoideum G alpha protein subunit G alpha 2: expression of a dominant negative protein inhibits proper prestalk to stalk differentiation.

Authors:  F Carrel; S Dharmawardhane; A M Clark; J A Powell-Coffman; R A Firtel
Journal:  Mol Biol Cell       Date:  1994-01       Impact factor: 4.138

8.  Mutation of cysteine 214 in Gi1 alpha subunit abolishes its endogenous GTPase activity.

Authors:  Yuren Wang; Gregory Tawa; Deborah Smith; Girija Krishnamurthy; Kathleen H Young
Journal:  Biochem J       Date:  2004-05-01       Impact factor: 3.857

9.  A mutation in the putative Mg(2+)-binding site of Gs alpha prevents its activation by receptors.

Authors:  J D Hildebrandt; R Day; C L Farnsworth; L A Feig
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

10.  Galpha Gbetagamma dissociation may be due to retraction of a buried lysine and disruption of an aromatic cluster by a GTP-sensing Arg Trp pair.

Authors:  Andrew F Neuwald
Journal:  Protein Sci       Date:  2007-11       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.